Clinical Trials Browser

Phase 3 × Immune Checkpoint Inhibitors × 30 days × Clear all

NCT07541755 2026-04-21

PD1-VEN-CAG

Phase 3 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06964568 2026-04-17

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Phase 3 Recruiting

Gastrointestinal

Esophageal Neoplasms